Clinical and Molecular Hepatology

"Chih-Cheng Lai"

Letters to the Editor

Early cancer risk reduction after GLP-1RA use: Signal or bias?: Letter to the editor on “Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study”: Shio-Shin Jean, Chih-Cheng Lai; Clin Mol Hepatol 2026;32(2):e163-e164.
Published online June 9, 2025; DOI: https://doi.org/10.3350/cmh.2025.0583

Citations

Citations to this article as recorded by

Correspondence to letter to the editor 1 on “Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study
Xianhua Mao, Mindie H. Nguyen
Clinical and Molecular Hepatology.2026; 32(2): e231. CrossRef